351 related articles for article (PubMed ID: 31921195)
21. Genome-wide transcriptional profiling identifies potential signatures in discriminating active tuberculosis from latent infection.
Pan L; Wei N; Jia H; Gao M; Chen X; Wei R; Sun Q; Gu S; Du B; Xing A; Zhang Z
Oncotarget; 2017 Dec; 8(68):112907-112916. PubMed ID: 29348876
[TBL] [Abstract][Full Text] [Related]
22. A combination of iron metabolism indexes and tuberculosis-specific antigen/phytohemagglutinin ratio for distinguishing active tuberculosis from latent tuberculosis infection.
Luo Y; Xue Y; Lin Q; Tang G; Yuan X; Mao L; Song H; Wang F; Sun Z
Int J Infect Dis; 2020 Aug; 97():190-196. PubMed ID: 32497795
[TBL] [Abstract][Full Text] [Related]
23. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
[TBL] [Abstract][Full Text] [Related]
24. Specific Host Signatures for the Detection of Tuberculosis Infection in Children in a Low TB Incidence Country.
Dreesman A; Corbière V; Libin M; Racapé J; Collart P; Singh M; Locht C; Mascart F; Dirix V
Front Immunol; 2021; 12():575519. PubMed ID: 33790886
[TBL] [Abstract][Full Text] [Related]
25. Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model.
Guirado E; Mbawuike U; Keiser TL; Arcos J; Azad AK; Wang SH; Schlesinger LS
mBio; 2015 Feb; 6(1):e02537-14. PubMed ID: 25691598
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the transcriptional immune biomarkers in peripheral blood from Warao indigenous associate with the infection by Mycobacterium tuberculosis.
Araujo Z; Palacios A; Enciso-Moreno L; Lopez-Ramos JE; Wide A; Waard JH; Rivas-Santiago B; Serrano CJ; Bastian-Hernandez Y; Castañeda-Delgado JE; Enciso-Moreno JA
Rev Soc Bras Med Trop; 2019 May; 52():e20180516. PubMed ID: 31141056
[TBL] [Abstract][Full Text] [Related]
27. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
[TBL] [Abstract][Full Text] [Related]
28. Identification of latent tuberculosis infection-related microRNAs in human U937 macrophages expressing Mycobacterium tuberculosis Hsp16.3.
Meng QL; Liu F; Yang XY; Liu XM; Zhang X; Zhang C; Zhang ZD
BMC Microbiol; 2014 Feb; 14():37. PubMed ID: 24521422
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic performance of GM-CSF and IL-2 in response to long-term specific-antigen cell stimulation in patients with active and latent tuberculosis infection.
Balcells ME; Ruiz-Tagle C; Tiznado C; García P; Naves R
Tuberculosis (Edinb); 2018 Sep; 112():110-119. PubMed ID: 30205963
[TBL] [Abstract][Full Text] [Related]
30. Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis.
Della Bella C; Spinicci M; Grassi A; Bartalesi F; Benagiano M; Truthmann K; Tapinassi S; Troilo A; D'Elios S; Alnwaisri H; Shuralev E; Singh M; Bartoloni A; D'Elios MM
PLoS One; 2018; 13(6):e0197825. PubMed ID: 29856871
[TBL] [Abstract][Full Text] [Related]
31. Novel serological biomarker panel using protein microarray can distinguish active TB from latent TB infection.
Li J; Wang Y; Yan L; Zhang C; He Y; Zou J; Zhou Y; Zhong C; Zhang X
Microbes Infect; 2022; 24(8):105002. PubMed ID: 35598729
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection.
Luo J; Zhang M; Yan B; Li F; Guan S; Chang K; Jiang W; Xu H; Yuan T; Chen M; Deng S
J Infect; 2019 Apr; 78(4):281-291. PubMed ID: 30528869
[TBL] [Abstract][Full Text] [Related]
33. Characterization of CD4/CD8+ αβ and Vγ2Vδ2+ T cells in HIV-negative individuals with different Mycobacterium tuberculosis infection statuses.
Gao Y; Zhang S; Ou Q; Shen L; Wang S; Wu J; Weng X; Chen ZW; Zhang W; Shao L
Hum Immunol; 2015 Nov; 76(11):801-7. PubMed ID: 26429305
[TBL] [Abstract][Full Text] [Related]
34. A novel chemokine biomarker to distinguish active tuberculosis from latent tuberculosis: a cohort study.
Li H; Ren W; Liang Q; Zhang X; Li Q; Shang Y; Ma L; Li S; Pang Y
QJM; 2023 Dec; 116(12):1002-1009. PubMed ID: 37740371
[TBL] [Abstract][Full Text] [Related]
35. Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype.
Nonghanphithak D; Reechaipichitkul W; Namwat W; Naranbhai V; Faksri K
Tuberculosis (Edinb); 2017 Jul; 105():28-34. PubMed ID: 28610785
[TBL] [Abstract][Full Text] [Related]
36. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
[TBL] [Abstract][Full Text] [Related]
37. Detection of immune cell response to M. tuberculosis-specific antigens by quantitative polymerase chain reaction.
Bibova I; Linhartova I; Stanek O; Rusnakova V; Kubista M; Suchanek M; Vasakova M; Sebo P
Diagn Microbiol Infect Dis; 2012 Jan; 72(1):68-78. PubMed ID: 22085772
[TBL] [Abstract][Full Text] [Related]
38. Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy.
Zhou Y; Du J; Hou HY; Lu YF; Yu J; Mao LY; Wang F; Sun ZY
Front Cell Infect Microbiol; 2017; 7():457. PubMed ID: 29164066
[TBL] [Abstract][Full Text] [Related]
39. Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease.
Burel JG; Singhania A; Dubelko P; Muller J; Tanner R; Parizotto E; Dedicoat M; Fletcher TE; Dunbar J; Cunningham AF; Lindestam Arlehamn CS; Catanzaro DG; Catanzaro A; Rodwell T; McShane H; O'Shea MK; Peters B
Tuberculosis (Edinb); 2021 Dec; 131():102127. PubMed ID: 34555657
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of IFIT3 and ORM1 as Biomarkers for Discriminating Active Tuberculosis from Latent Infection.
Yang BF; Zhai F; Yu S; An HJ; Cao ZH; Liu YH; Wang R; Cheng XX
Curr Med Sci; 2022 Dec; 42(6):1201-1212. PubMed ID: 36462134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
